SEARCH

SEARCH BY CITATION

References

  • Barat LM, Himonga B, Nkunika S et al. (1998) A systematic approach to the development of a rational malaria treatment policy in Zambia. Tropical Medicine and International Health 3, 535542.
  • Bayoumi R, Babiker H, Ibrahim S et al. (1989) Chloroquine-resistant Plasmodium falciparum in Eastern Sudan. Acta Tropica 46, 157165.
  • Bloland PB & Ettling M (1999) Making malaria-treatment policy in the face of drug resistance. Annals of Tropical Medicine and Parasitology 93, 523.
  • Bloland PB, Ettling M & Meek S (2000) Combination therapy for malaria in Africa: hype or hope? Bulletin of the World Health Organization 78, 13741491.
  • Bloland PB, Kazembe PN, Oloo AJ, Barat LM & Ruebush TK (1998) Chloroquine in Africa: critical assessment and recommendations for monitoring and evaluating chloroquine therapy efficacy in sub-Saharan Africa. Tropical Medicine and International Health 3, 543552.
  • Bloland PB, Lackritz EM, Kazembe PN et al. (1993) Beyond chloroquine: implications of drug resistance for evaluating malaria therapy efficacy and treatment policy in Africa. Journal of Infectious Diseases 167, 932927.
  • Brandling-Bennett AD, Oloo AJ, Watkins WM et al. (1988) Chloroquine treatment of falciparum malaria in an area of Kenya of intermediate chloroquine resistance. Transactions of the Royal Society of Tropical Medicine and Hygiene 82, 833837.
  • Brasseur P, Guiguemde R, Diallo S et al. (1999) Amodiaquine remains effective for treating uncomplicated malaria in west and central Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 645650.
  • Campbell CC (1991) Challenges facing antimalarial therapy in Africa. Journal of Infectious Diseases 16, 12071211.
  • Van Dillen J, Custers M, Wensink A et al. (1999) A comparison of amodiaquine and sulfadoxine-pyrimethamine as first-line treatment of falciparum malaria in Kenya. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 185188.
  • Dorsey G, Kamya MR, Ndeezi G et al. (2000) Predictors of chloroquine treatment failure in children and adults with falciparum malaria in Kampala, Uganda. American Journal of Tropical Medicine and Hygiene 62, 686692.
  • Dorsey G, Njama D, Kamya MR & Rosenthal P (2001) A Longitudinal Assessment of Different First-Line Therapies for Uncomplicated Falciparum Malaria in Kampala, Uganda. 50th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Atlanta.
  • Fowler V, Lemnge M, Irare S et al. (1993) Efficacy of chloroquine on Plasmodium falciparum transmitted in Amani eastern Usambara Mountains, northeast Tanzania: an area where malaria has recently become endemic. Journal of Tropical Medicine and Hygiene 49, 337345.
  • Gasasira A, Kamya MR, Nzarubara B et al. (2001) Chloroquine or Amodiaquine Combined with Sulfadoxine-Pyrimethamine as a Treatment for Uncomplicated Malaria in Uganda. 50th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Atlanta.
  • Gorissen E, Ashruf G, Lamboo M et al. (2000) In vivo efficacy study of amodiaquine and sulfadoxine/ pyrimethamine in Kibwezi, Kenya and Kigoma, Tanzania. Tropical Medicine and International Health 5, 459463.
  • Hoffman SL, Masbar S, Hussein P et al. (1984) Absence of malaria mortality in villagers with chloroquine-resistant Plasmodium falciparum treated with chloroquine. Transactions of the Royal Society of Tropical Medicine and Hygiene 78, 175178.
  • Kamugisha J, Kipp W & Burnham G (1994) In vivo sensitivity of Plasmodium falciparum to chloroquine amodiaquine and sulfadoxine-pyrimethamine in Western Uganda. Tropical and Geographic Medicine 46, 364365.
  • Kamya MR, Dorsey G, Gasasira A et al. (2001) The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. Transactions of the Royal Society of Tropical Medicine and Hygiene 95, 5055.
  • Kilian AHD, Prislin I, Kabagambe G et al. (1997) In vivo resistance of Plasmodium falciparum to chloroquine sulphadoxine-pyrimethamine and co-trimoxazole in Kabarole and Bundibugyo Districts, Uganda. Unpublished report.
  • Legros D, Johnson K & Houpikian P (1998) Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Mbarara, South-Western Uganda. Unpublished report.
  • McIntosh HM & Greenwood BM (1998) Chloroquine or amodiaquine combined with sulfadoxine-pyrimethamine as a treatment for uncomplicated malaria – a systematic review. Annals of Tropical Medicine and Parasitology 93, 265270.
  • Ndyomugyenyi R & Magnussen P (1997) In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in school children in Hoima district, Western Uganda. Acta Tropica 66, 137143.
  • Ndyomugyenyi R & Magnussen P (2000) In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine among schoolchildren in rural Uganda: a comparison between 1995 and 1998. Acta Tropica 76, 265270.
  • Nevill CG, Ochen K, Munafu CG, Bekobita D & Sezi CL (1995) Response of Plasmodium falciparum to chloroquine and Fansidar in vivo and chloroquine and amodiaquine in vitro. Uganda. East African Medical Journal 72, 349354.
  • Nosten F, Van Vugt M, Price R et al. (2000) Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356, 297302.
  • Nzila-Mounda AM, Mberu EK, Sibley CH et al. (1998) Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain. Antimicrobial Agents Chemotherapy 42, 164169.
  • Olliaro P, Nevill C, LeBras J et al. (1996) Systematic review of amodiaquine treatment in uncomplicated malaria. Lancet 348, 11961201.
  • Phillips-Howard PA & West LJ (1990) Serious adverse drug reactions to pyrimethamine-sulphadoxine pyrimethamine-dapsone and to amodiaquine in Britain. Journal of the Royal Society of Medicine 83, 8285.
  • Premji Z, Minjas JN & Shiff CJ (1993) Chloroquine resistant Plasmodium falciparum. coastal Tanzania. A challenge to the continued strategy of village based chemotherapy for malaria control. Tropical Medicine and Parasitology 45, 4748.
  • Price RN, Nosten F, Luxemburger C et al. (1996) Effects of artemisinin derivatives on malaria transmissibility. Lancet 347, 16541658.
  • Schapira A, Beales PF & Halloran M (1993) Malaria: living with drug resistance. Parasitolology Today 9, 168174.
  • Von Seidlein L, Milligan P, Pinder M et al. (2000) Efficacy of artesunate plus pyrimethamine-sulfadoxine for uncomplicated malaria in Gambian children: a double-blind randomized controlled trial. Lancet 355, 352357.
  • Sexton JD, Deloron P, Bugilimfura L, Ntilivamunda A & Neill M (1988) Parasitologic and clinical efficacy of 25 and 50 mg/kg of chloroquine for treatment of Plasmodium falciparum malaria in Rwandan children. American Journal of Tropical Medicine and Hygiene 38, 237243.
  • Shretta R, Omumbo J, Rapuoda B & Snow RW (2000) Using evidence to change antimalarial drug policy in Kenya. Tropical Medicine and International Health 5, 755764.
  • Staedke S, Kamya M, Dorsey G et al. (2001) A randomized trial of amodiaquine sulfadoxine-pyrimethamine and combination therapy for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. Lancet 358, 368374.
  • Sturchler D, Mittelholzer ML & Kerr L (1993) How frequent are notified severe cutaneous adverse reactions to Fansidar? Drug Safety 8, 160168.
  • Sudre P, Breman JG, McFarland D & Koplan JP (1992) Treatment of chloroquine-resistant malaria in African children: a cost-effectiveness analysis. International Journal of Epidemiology 21, 146154.
  • Trape JF (2001) The public health impact of chloroquine resistance in Africa. American Journal of Tropical Medicine and Hygiene 64, 1217.
  • Watkins WM, Percy M, Crampton JM et al. (1988) The changing response of Plasmodium falciparum to antimalarial drugs in East Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 82, 2126.
  • White NJ (1999) Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia 41, 301308.
  • WHO (1973) Chemotherapy of Malaria and Resistance to Antimalarials. WHO, Geneva. WHO Technical Report Series, No. 529.
  • WHO (1994) Antimalarial Drug Policies: Data Requirements, Treatment of Uncomplicated Malaria, and Management of Malaria in Pregnancy. WHO, Geneva. WHO/MAL/94.1070.
  • WHO (1996) Assessment of Therapeutic Efficacy of Antimalarial Drugs: For Uncomplicated Falciparum Malaria in Areas with Intense Transmission. WHO, Geneva. WHO/MAL/96.1077.
  • Wolday D, Kibreab T, Bukenya D & Hodes R (1995) Sensitivity of Plasmodium falciparum in vivo to chloroquine and pyrimethamine-sulfadoxine in Rwandan patients in a refugee camp in Zaire. Transactions of the Royal Society of Tropical Medicine and Hygiene 89, 654656.
  • Wongsrichanalai C, Thimansarn K & Sirichaisinthop J (2000) Antimalarial drug combination policy: a caveat. Lancet 355, 22452247.